Literature DB >> 18671966

Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells.

Ryuji Ikeda1, Ken-ichi Iwashita, Tomoyuki Sumizawa, Shun-ichi Beppu, Sho Tabata, Yusuke Tajitsu, Yuichi Shimamoto, Kenichi Yoshida, Tatsuhiko Furukawa, Xiao-Fang Che, Tatsuya Yamaguchi, Mina Ushiyama, Akihiko Miyawaki, Yasuo Takeda, Masatatsu Yamamoto, Hong-Ye Zhao, Yoshihiko Shibayama, Katsushi Yamada, Shin-ichi Akiyama.   

Abstract

The major vault protein (MVP) is the major constituent of the vault particle, the largest ribonuclear protein complex described to date and is identical to lung resistance-related protein (LRP). Although MVP is also expressed in several normal tissues, little is known about its physiological role. MVP played a protective role against some xenobiotics and other stresses. We thus investigated the effect of osmotic stress on MVP expression by treating human colon cancer SW620 cells with sucrose or NaCl. The expression level of both MVP protein and MVP mRNA was increased by the osmostress. Sucrose or sodium chloride could also enhance MVP promoter activity. Inhibition of p38 MAPK in SW620 cells by SB203580 inhibited the expression of MVP under hyperosmotic stress. These findings suggested that osmotic stress up-regulated the MVP expression through p38 MAPK pathway. Down-regulation of MVP expression by MVP interfering RNA (RNAi) in SW620 cells increased the sensitivity of the cells to hyperosmotic stress and enhanced apoptosis. Furthermore, MVP RNAi prevented the osmotic stress-induced, time-dependent increase in phosphorylated Akt. These findings suggest that the PI3K/Akt pathway might be implicated in the cytoprotective effect of MVP. Our data demonstrate that exposure of cells to hyperosmotic stress induces MVP that might play an important role in the protection of the cells from the adverse effects of osmotic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671966     DOI: 10.1016/j.yexcr.2008.07.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

1.  An in vitro paradigm for diabetic cerebral oedema and its therapy: a critical role for taurine and water channels.

Authors:  Ildi H Koves; Vincenzo C Russo; Sandra Higgins; Avantika Mishra; James Pitt; Fergus J Cameron; George A Werther
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

2.  Radiation- and chemoinduced multidrug resistance in colon carcinoma cells.

Authors:  Detlef Bartkowiak; Michael Stempfhuber; Thomas Wiegel; Dirk Bottke
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

3.  Major vault protein regulates class A scavenger receptor-mediated tumor necrosis factor-α synthesis and apoptosis in macrophages.

Authors:  Jingjing Ben; Yan Zhang; Rongmei Zhou; Haiyang Zhang; Xudong Zhu; Xiaoyu Li; Hanwen Zhang; Nan Li; Xiaodan Zhou; Hui Bai; Qing Yang; Donghai Li; Yong Xu; Qi Chen
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

Review 4.  Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

Authors:  Song He; Dechun Zhang; Fang Cheng; Fanghong Gong; Yanan Guo
Journal:  Mol Biol Rep       Date:  2009-01-01       Impact factor: 2.316

5.  Effects of fluctuating glucose levels on neuronal cells in vitro.

Authors:  Vincenzo C Russo; Sandra Higgins; George A Werther; Fergus J Cameron
Journal:  Neurochem Res       Date:  2012-05-08       Impact factor: 3.996

6.  Prolonged morphine administration alters protein expression in the rat myocardium.

Authors:  Zdenka Drastichova; Jitka Skrabalova; Jan Neckar; Frantisek Kolar; Jiri Novotny
Journal:  J Biomed Sci       Date:  2011-11-30       Impact factor: 8.410

7.  NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and "osmotic reprogramming" in colorectal cancer.

Authors:  Gertrud Knoll; Petra Riffelsberger; Danielle Raats; Onno Kranenburg; Martin Ehrenschwender
Journal:  Cell Death Dis       Date:  2020-04-20       Impact factor: 8.469

8.  Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.

Authors:  Lichan Yuan; Na Zhao; Junyi Wang; Yuying Liu; Li Meng; Shuyu Guo; Erik A C Wiemer; Qi Chen; Yelin Mao; Jingjing Ben; Junqing Ma
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

9.  Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

Authors:  Daniela Lötsch; Elisabeth Steiner; Klaus Holzmann; Sabine Spiegl-Kreinecker; Christine Pirker; Juraj Hlavaty; Helga Petznek; Balazs Hegedus; Tamas Garay; Thomas Mohr; Wolfgang Sommergruber; Michael Grusch; Walter Berger
Journal:  Oncotarget       Date:  2013-11

10.  3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.

Authors:  Hiroto Fukushima; Tetsuya Abe; Kazuki Sakamoto; Hiroaki Tsujimoto; Shinji Mizuarai; Shinji Oie
Journal:  BMC Cancer       Date:  2014-08-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.